ClinicalTrials.Veeva

Menu

Combined Social Worker and Pharmacist Transitional Care Program

Rush logo

Rush

Status

Completed

Conditions

Patient Admission
Patient Discharge

Treatments

Behavioral: No Intervention: Usual Care
Behavioral: Combined Social Worker and Pharmacist Program

Study type

Interventional

Funder types

Other

Identifiers

NCT01503554
11010702-IRB01
Care Trans-IT (Other Grant/Funding Number)

Details and patient eligibility

About

In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors that can lead to rehospitalization. This study will evaluate the impact of this program on 30-day same hospital readmission rates and total cost of care.

Full description

If a patient is enrolled in the Combined Social Worker and Pharmacist Program their care will differ from usual care in a number of different ways. First, while the patient is in the hospital, an interdisciplinary group of providers will round on the patient on a regular basis. This interdisciplinary team will be composed of an attending physician, clinical pharmacist, nurse, case manager, and social worker, who will all evaluate the patient's needs from a variety of perspectives to ensure that the patient is prepared for discharge and self-manage post-discharge. During the patient's hospital stay, a clinical pharmacist will also conduct a detailed medication reconciliation of home medications, assess medication-related risks, and provide relevant education to patients participating in the program. After the patient is discharged from Rush University Medical Center, a Master's prepared social worker will then contact the patient and conduct an assessment from a psychosocial perspective to identify any unmet needs. Lastly, a clinical pharmacist will be available to patients enrolled in the Combined Social Worker and Pharmacist Program, should they have any medication-related questions post-discharge.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18
  • Planned discharge to home or home health
  • English-speaking
  • At least one of the following risk factors:
  • Use of high risk medication(s): Anti-coagulant therapy, dual ASA/plavix therapy, anticholinergic agent, digoxin, opioids, psychotropic medications, or erythrocyte stimulating factor
  • Clinical risk factor: Depression, fall risk, limited functional capacity, substance abuse, dementia
  • Psycho-social risk factor: high care giver burden, family conflict, limited health literacy, lives alone, significant patient stress, transportation concerns, health care scheduling concerns, inadequate emotional support.

Exclusion criteria

  • Hospice
  • Solid organ transplant
  • End-stage renal disease
  • Current chemotherapy or radiation therapy

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Social Worker + Pharmacist Intervention
Experimental group
Description:
Intervention arm offering enhanced services from a social worker and a pharmacist post-discharge
Treatment:
Behavioral: Combined Social Worker and Pharmacist Program
Usual Care
Experimental group
Description:
Patients receiving usual care will have a medication reconciliation performed by a physician or nurse during their hospital stay. No further support or interventions are provided post discharge.
Treatment:
Behavioral: No Intervention: Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems